Reaction Details Report a problem with these data
Target
Epidermal growth factor receptor [695-1022]
Ligand
BDBM525472
Substrate
n/a
Meas. Tech.
Biochemical EGFR Inhibition Assays (100 mM ATP)
IC50
549±n/a nM
Citation
 Boese, D; Dahmann, G; Engelhardt, H; Petronczki, M; Scharn, D Benzimidazole compounds and derivatives as EGFR inhibitors US Patent  US11174245 Publication Date 11/16/2021 
Target
Name:
Epidermal growth factor receptor [695-1022]
Synonyms:
EGFR | EGFR (aa 695-1022) | EGFR_HUMAN | ERBB | ERBB1 | HER1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
37339.79
Organism:
Homo sapiens (Human)
Description:
P00533[695-1022]
Residue:
328
Sequence:
SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG
  
Inhibitor
Name:
BDBM525472
Synonyms:
US11174245, # I-109
Type:
Small organic molecule
Emp. Form.:
C27H28N4O3
Mol. Mass.:
456.5362
SMILES:
COc1ccccc1-c1cc(ccn1)C(=O)\N=c1/[nH]c2cc(C)ccc2n1[C@@H]1CC[C@H](O)CC1 |r,wU:27.30,30.34,(2.42,-1.74,;3.19,-.4,;4.73,-.4,;5.5,-1.74,;7.04,-1.74,;7.81,-.4,;7.04,.93,;5.5,.93,;4.73,2.26,;3.19,2.26,;2.42,3.6,;3.19,4.93,;4.73,4.93,;5.5,3.6,;.88,3.6,;.11,4.93,;.11,2.26,;-1.43,2.26,;-2.34,3.51,;-3.8,3.03,;-5.14,3.8,;-6.47,3.03,;-7.81,3.8,;-6.47,1.49,;-5.14,.72,;-3.8,1.49,;-2.34,1.02,;-1.94,-.47,;-3.03,-1.56,;-2.63,-3.05,;-1.14,-3.44,;-.75,-4.93,;-.06,-2.36,;-.45,-.87,)|
Structure:
Search PDB for entries with ligand similarity: